BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 23732467)

  • 1. Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy.
    Bruno S; Saibeni S; Bagnardi V; Vandelli C; De Luca M; Felder M; Fracanzani AL; Prisco C; Vitaliani G; Simone L; Gaeta GB; Stanzione M; Persico M; Furlan C; Stroffolini T; Salerno F; Maisonneuve P; Almasio PL;
    Am J Gastroenterol; 2013 Jul; 108(7):1112-22. PubMed ID: 23732467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural History of Cirrhosis of Liver after First Decompensation: A Prospective Study in India.
    Shah AS; Amarapurkar DN
    J Clin Exp Hepatol; 2018 Mar; 8(1):50-57. PubMed ID: 29743797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.
    Bruno S; Zuin M; Crosignani A; Rossi S; Zadra F; Roffi L; Borzio M; Redaelli A; Chiesa A; Silini EM; Almasio PL; Maisonneuve P
    Am J Gastroenterol; 2009 May; 104(5):1147-58. PubMed ID: 19352340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications].
    Gentilini P; Laffi G; La Villa G; Casini-Raggi V; Romanelli RG; Buzzelli G; Mazzanti R; Marra F; Pinzani M; Zignego AL
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():23S-29S. PubMed ID: 9004817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different patterns of decompensation in patients with alcoholic vs. non-alcoholic liver cirrhosis.
    Wiegand J; Kühne M; Pradat P; Mössner J; Trepo C; Tillmann HL
    Aliment Pharmacol Ther; 2012 Jun; 35(12):1443-50. PubMed ID: 22530565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of hepatitis B virus-related cirrhotic patients hospitalized to control ascites.
    Kim SU; Han KH; Nam CM; Park JY; Kim DY; Chon CY; Ahn SH
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1722-7. PubMed ID: 18717757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes Is Associated with Clinical Decompensation Events in Patients with Cirrhosis.
    Liu TL; Trogdon J; Weinberger M; Fried B; Barritt AS
    Dig Dis Sci; 2016 Nov; 61(11):3335-3345. PubMed ID: 27480088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Laennec staging system for histological sub-classification of cirrhosis is useful for stratification of prognosis in patients with liver cirrhosis.
    Kim SU; Oh HJ; Wanless IR; Lee S; Han KH; Park YN
    J Hepatol; 2012 Sep; 57(3):556-63. PubMed ID: 22617153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients.
    Planas R; Ballesté B; Alvarez MA; Rivera M; Montoliu S; Galeras JA; Santos J; Coll S; Morillas RM; Solà R
    J Hepatol; 2004 May; 40(5):823-30. PubMed ID: 15094231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural history of hepatitis B virus cirrhosis after the first hepatic decompensation in Tunisia.
    Jmaa A; Ksiaa M; Ben Slama A; Kahloun A; Jmaa R; Harrabi I; Golli L; Ajmi S
    Tunis Med; 2012 Feb; 90(2):172-6. PubMed ID: 22407631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study.
    Jepsen P; Ott P; Andersen PK; Sørensen HT; Vilstrup H
    Hepatology; 2010 May; 51(5):1675-82. PubMed ID: 20186844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C.
    Sanyal AJ; Banas C; Sargeant C; Luketic VA; Sterling RK; Stravitz RT; Shiffman ML; Heuman D; Coterrell A; Fisher RA; Contos MJ; Mills AS
    Hepatology; 2006 Apr; 43(4):682-9. PubMed ID: 16502396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical course of decompensated alcoholic cirrhosis: a prospective study of 165 patients.
    Alvarez MA; Cirera I; Solà R; Bargalló A; Morillas RM; Planas R
    J Clin Gastroenterol; 2011; 45(10):906-11. PubMed ID: 21814145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score.
    Huo TI; Lin HC; Lee FY; Hou MC; Lee PC; Wu JC; Chang FY; Lee SD
    Liver Int; 2006 Feb; 26(1):55-61. PubMed ID: 16420510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with liver cirrhosis show worse survival if decompensation occurs later during course of disease than at diagnosis.
    Nilsson E; Anderson H; Sargenti K; Lindgren S; Prytz H
    Scand J Gastroenterol; 2018 Apr; 53(4):475-481. PubMed ID: 29513096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of bleeding esophageal varices with cyanoacrylate and polidocanol, or polidocanol alone: results of a prospective study in an unselected group of patients with cirrhosis of the liver.
    Lux G; Retterspitz M; Stabenow-Lohbauer U; Langer M; Altendorf-Hofmann A; Bozkurt T
    Endoscopy; 1997 May; 29(4):241-6. PubMed ID: 9255525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis.
    Praktiknjo M; Simón-Talero M; Römer J; Roccarina D; Martínez J; Lampichler K; Baiges A; Low G; Llop E; Maurer MH; Zipprich A; Triolo M; Maleux G; Fialla AD; Dam C; Vidal-González J; Majumdar A; Picón C; Toth D; Darnell A; Abraldes JG; López M; Jansen C; Chang J; Schierwagen R; Uschner F; Kukuk G; Meyer C; Thomas D; Wolter K; Strassburg CP; Laleman W; La Mura V; Ripoll C; Berzigotti A; Calleja JL; Tandon P; Hernandez-Gea V; Reiberger T; Albillos A; Tsochatzis EA; Krag A; Genescà J; Trebicka J;
    J Hepatol; 2020 Jun; 72(6):1140-1150. PubMed ID: 31954206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of portal hypertension on prognosis in patients with decompensated liver cirrhosis].
    Zhang JY; Kuai JH; Jia JD; Wang BE; Qin CY
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):263-5. PubMed ID: 19403023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.